KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Idexx Laboratories (IDXX) Receivables - Net (2016 - 2025)

Idexx Laboratories has reported Receivables - Net over the past 17 years, most recently at $552.4 million for Q4 2025.

  • Quarterly results put Receivables - Net at $552.4 million for Q4 2025, up 16.64% from a year ago — trailing twelve months through Dec 2025 was $552.4 million (up 16.64% YoY), and the annual figure for FY2025 was $552.4 million, up 16.64%.
  • Receivables - Net for Q4 2025 was $552.4 million at Idexx Laboratories, down from $566.9 million in the prior quarter.
  • Over the last five years, Receivables - Net for IDXX hit a ceiling of $566.9 million in Q3 2025 and a floor of $368.3 million in Q4 2021.
  • Median Receivables - Net over the past 5 years was $455.1 million (2023), compared with a mean of $458.2 million.
  • Biggest five-year swings in Receivables - Net: increased 27.27% in 2021 and later rose 3.0% in 2022.
  • Idexx Laboratories' Receivables - Net stood at $368.3 million in 2021, then increased by 8.76% to $400.6 million in 2022, then grew by 14.18% to $457.4 million in 2023, then increased by 3.53% to $473.6 million in 2024, then rose by 16.64% to $552.4 million in 2025.
  • The last three reported values for Receivables - Net were $552.4 million (Q4 2025), $566.9 million (Q3 2025), and $560.6 million (Q2 2025) per Business Quant data.